Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP171282.RALc1Sw9AUWSsUWyeleGNkp1WOfxbvNEjhbkAHUA7u-lo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP171282.RALc1Sw9AUWSsUWyeleGNkp1WOfxbvNEjhbkAHUA7u-lo130_assertion type Assertion NP171282.RALc1Sw9AUWSsUWyeleGNkp1WOfxbvNEjhbkAHUA7u-lo130_head.
- NP171282.RALc1Sw9AUWSsUWyeleGNkp1WOfxbvNEjhbkAHUA7u-lo130_assertion description "[Furthermore, some endometrioid carcinomas and serous cystadenocarcinomas of the ovary and some ovarian cancers in stages III and IV expressed remarkably high levels of PD-ECGF and its mRNA.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP171282.RALc1Sw9AUWSsUWyeleGNkp1WOfxbvNEjhbkAHUA7u-lo130_provenance.
- NP171282.RALc1Sw9AUWSsUWyeleGNkp1WOfxbvNEjhbkAHUA7u-lo130_assertion evidence source_evidence_literature NP171282.RALc1Sw9AUWSsUWyeleGNkp1WOfxbvNEjhbkAHUA7u-lo130_provenance.
- NP171282.RALc1Sw9AUWSsUWyeleGNkp1WOfxbvNEjhbkAHUA7u-lo130_assertion SIO_000772 9563652 NP171282.RALc1Sw9AUWSsUWyeleGNkp1WOfxbvNEjhbkAHUA7u-lo130_provenance.
- NP171282.RALc1Sw9AUWSsUWyeleGNkp1WOfxbvNEjhbkAHUA7u-lo130_assertion wasDerivedFrom befree-20140225 NP171282.RALc1Sw9AUWSsUWyeleGNkp1WOfxbvNEjhbkAHUA7u-lo130_provenance.
- NP171282.RALc1Sw9AUWSsUWyeleGNkp1WOfxbvNEjhbkAHUA7u-lo130_assertion wasGeneratedBy ECO_0000203 NP171282.RALc1Sw9AUWSsUWyeleGNkp1WOfxbvNEjhbkAHUA7u-lo130_provenance.